No Detail Found!

Recent advance in lipid management: Focus on PCSK9I (Proprote in Convertase Subtilisin/ Kexin 9 Inhibitors).

Author(s)
Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India
Abstract
This review discusses recent advances in lipid management, focusing on a new class of drugs known as pcsk9i (proprotein convertase subtilisin/ kexin 9 inhibitors. It describes the basic and clinical pharmacology of these drugs.
Publication Details
Page(s) 1191-1193
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 9, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

84

Views